ABHD11 and non-small cell lung carcinoma: There is m6 A methyltransferase-like 3 (METTL3) in the upstream of lncRNA ABHD11-AS1, which could promote the expression of ABHD11-AS1, and the prognosis for NSCLC patients will get worse (45).